Grant RDF
pages:- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- more...
- A Phase 1B, Rndm...Single Doses of Gs-9256 in Subjects With Chronic Hepatitis C Genotpye I Infection
- A Phase 1B/2 Randomized Phase 2 Study Evaluating the Evaluating the Efficacy of Doxorubicin With or Without.....
- A Phase 1b/2a Study to Evaluate the Effect of Aerosolized, R Ecombinant Alpha 1-Antitrypsin On
- A Phase 2 Open Label Multicenter Multicohort Study to Investigate the Safety and Efficacy of Ledipasvir/Sofosbuvir
- A Phase 2 open-label study in patients with recurrent Genotype 1 hepAtitis C post-orthotopic Liver transplAnt to eXplore the safety and efficacY of simeprevir and sofosbuvir with and without ribavirin
- A Phase 2 Open-Label Study in Patients With Recurrent Genotype 1 Hepatitis C Post-Orthotopic Liver Transplant...
- A Phase 2 Placebo Controlled Dbl Blind Randomized Clinical Study to Determine Safety Tolerability and Efficacy Of.....
- A Phase 2 Randomized Double Blind Placebo Controlled Repeat Dose Study of Kb001-a in Subjects With Cystic Fibrosis......
- A Phase 2 Randomized, Open-Label Study of GS-5885 Administered Concomitantly with GS-9451, Tegobuvir and Ribavirin (RBV) to Treatment-Naïve Subjects with Chronic Genotype1 HCV Infection
- A Phase 2 Randomoized Double Blind Placobo Controlled Multicenter Dose Ranging Study of Cicletanine in Subjects With....
- A Phase 2 Study of Recombinant Human Thrombin(Rhthrombin) Administered Using a Spray Applicator in the Subjects.........
- A Phase 2 Study of VX-950 in Combination With Peginterferon Alfa-2a (Pegasys) With Ribavirin (Copegus) in Subjects with Genotype 1 Hepatitis C Who Have Not Received Prior Treatment
- A Phase 2 Study of Vx-950 in Combination With Peginterferon Alfa-2a (Pegasys)With & Without Ribavirin (Copegus) in .....
- A Phase 2, Dose Escalation Evaluation of the Pharmacokinetic and Hemodynamic Effects of Carperitide In...
- A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Efficacy, Safety and Tolerability of AST-120 (Spherical Carbon Adsorbent) for 8 Weeks in the Treatment of Mild Hepatic Encephalopathy
- A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate...Assistant-120
- A Phase 2, multicenter, multinational, randomized, double-blind, placebo-controlled parallel-group, clinical trial to evaluate the efficacy and safety of RPC4046 in adult subjects with esophagitis (EoE)
- A Phase 2, Multicenter, Open-Label Extension (OLE) Study to Observe the Long-Term Efficacy, Safety, and Tolerability of Repeated Adminstration of ABT-494 in Subjects with Crohn’s Disease
- A Phase 2, Multicenter, Open-Label, Active Comparator-Contldext Trial to Evaluation the Long-Term Safety & Eff of Cp690,550...
- A Phase 2, Multicenter, Randomized, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir + Gs-5816 for 12 Weeks in Treatment Experienced Subjects with Chronic HCV Infection
- A Phase 2, Multicenter, Randomized, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir + GS-5816 for 12 Weeks in Treatment Experienced Subjects with Chronic HCV Infection
- A Phase 2, Multicenter, Randomized, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir + GS-5816 for 12 Weeks in Treatment-Naïve Subjects with Chronic HCV Infection
- A Phase 2, Multicenter, Randomized, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir + GS-5816 for 12 Weeks in Treatment-Naïve Subjects with Chronic HCV Infection
- A Phase 2, Multicentre,Double-Blind, Placebo-Controlled Doseescalating Trial of the Safety, Pharmacokinetics,...........
- A Phase 2, Open Label, Multicenter, Randomized Trial Comparing Tivozanib in Combination With Mfolfox6 to . . .
- A Phase 2, Open-Label Study to Evaluate the Safety, Tolerability,and Efficacy of Subcutaneous Dose Levels of Rav
- A Phase 2, Open-Label, Multicenter, Multi-Cohort, Single-Armstudy to Investigate the Safety and Efficacy of Sofosbuvir..
- A Phase 2, Open-Label, Non-Comparative Study of Doripenem in the Treatment of Nosocomial and Ventilator-Associated
- A Phase 2, Proof of Concept, Randomized, Open-Label, Two-Arm, Parallel Group, Multi-Center Study to Assess the Efficacy
- A Phase 2, Randomized, Double-Blind, Placebo-Controlled Pilot Study to Assess the Effects of Rm-493, a Melanocortin